Bryan Love to Antineoplastic Agents
This is a "connection" page, showing publications Bryan Love has written about Antineoplastic Agents.
Connection Strength
0.168
-
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. Oncologist. 2019 04; 24(4):537-548.
Score: 0.096
-
Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. 2014 Dec; 15(13):e594-e605.
Score: 0.072